Clinical Trial Update: Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study [Phase 3]

View source ↗

Summary

A Phase 3 trial named LC-REVITALIZE is currently recruiting to test a repurposed drug for Long COVID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid

Snippet

Sponsor: Douglas D. Fraser | Conditions: Long COVID | Phase 3 | Status: RECRUITING